Fundraising Fox
/Companies
Sign in

Meissa Vaccines

San Francisco, US · Founded 2014 · Delaware corporation · 1 known investors

Find your way into Meissa Vaccines

Each arrow is one introduction. Sign up to fill in the first one.

262 people can intro you to Roderick

Ask Briac Bombrun to introduce you to Roderick Tang

You →Briac · together at International AIDS Vaccine Initiative (IAVI) →Roderick

Sign up to find every way you can get introduced to Meissa Vaccines

  • Your email: who you already know at Meissa Vaccines, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Meissa Vaccines team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in
Biotech

Founders & leadership

Meissa Vaccines was founded in 2014 by Martin Moore and Roderick Tang.

MMMartin Moore
Martin MooreCo-founder
RTRoderick Tang
Roderick TangCo-founder and Senior Vice President2014–2024Roderick Tang has worked in biotechnology with experience in vaccine discovery research and development. He is an executive officer and director at Meissa Vaccines.

Investors · 1

Funding

SEC filings, press & company announcements

$15.2M disclosed across 2 of 4 rounds · 2016–2019

▶$13.9MraisedOct 2019 · 37 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin MooreExecutive Officer, Director
  • Kenneth KelleyDirector
  • Stephanie O?BrienDirector
  • William DalyDirector
  • Isaac ChengDirector
  • Roderick TangExecutive Officer
Offering amount
$33.9M
Amount sold
$13.9M
First sale
Sep 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedOct 2017 · 14 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin MooreExecutive Officer, Director, Promoter
  • Roderick TangExecutive Officer, Director, Promoter
Offering amount
$5M
Amount sold
$1.2M
First sale
Jul 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2018$1.3M
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$224.1K
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$216.4K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who founded Meissa Vaccines?
Meissa Vaccines was founded by Martin Moore, Roderick Tang in 2014.
Who are Meissa Vaccines's investors?
Meissa Vaccines's investors include FundRx.
How much funding has Meissa Vaccines raised?
Meissa Vaccines has disclosed $15.2M raised across 2 of its 4 known rounds.
Where is Meissa Vaccines headquartered?
Meissa Vaccines is headquartered in San Francisco, US.